Literature DB >> 20866115

Chronic pruritus in the absence of specific skin disease: an update on pathophysiology, diagnosis, and therapy.

Nicoletta Cassano1, Gianpaolo Tessari, Gino A Vena, Giampiero Girolomoni.   

Abstract

Chronic pruritus is a major and distressing symptom of many cutaneous and systemic diseases and can significantly impair the patient's quality of life. Pruritus perception is the final result of a complex network involving dedicated nerve pathways and brain areas, and an increasing number of peripheral and central mediators are thought to be involved. Itch is associated with most cutaneous disorders and, in these circumstances, its management overlaps with that of the skin disease. Itch can also occur without associated skin diseases or primary skin lesions, but only with nonspecific lesions secondary to rubbing or scratching. Chronic itch with no or minimal skin changes can be secondary to important diseases, such as neurologic disorders, chronic renal failure, cholestasis, systemic infections, malignancies, and endocrine disorders, and may also result from exposure to some drugs. The search for the cause of pruritus usually requires a meticulous step-by-step assessment involving careful history taking as well as clinical examination and laboratory investigations. Few evidence-based treatments for pruritus are available. Topical therapy, oral histamine H(1) receptor antagonists, and phototherapy with UV radiation can target pruritus elicitation in the skin, whereas antiepileptic drugs, opioid receptor antagonists, and antidepressants can block signal processing in the CNS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20866115     DOI: 10.2165/11317620-000000000-00000

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  10 in total

1.  Pruritus in the elderly: clinical approaches to the improvement of quality of life.

Authors:  Kenneth R Cohen; Jerry Frank; Rebecca L Salbu; Igor Israel
Journal:  P T       Date:  2012-04

2.  [Chronic pruritus in autoimmune dermatoses : results of a comparative survey].

Authors:  L Schröder; M Hertl; E Chatzigeorgakidis; N Q Phan; S Ständer
Journal:  Hautarzt       Date:  2012-07       Impact factor: 0.751

3.  Oxidative stress induces itch via activation of transient receptor potential subtype ankyrin 1 in mice.

Authors:  Tong Liu; Ru-Rong Ji
Journal:  Neurosci Bull       Date:  2012-04       Impact factor: 5.203

Review 4.  Emerging role of Toll-like receptors in the control of pain and itch.

Authors:  Tong Liu; Yong-Jing Gao; Ru-Rong Ji
Journal:  Neurosci Bull       Date:  2012-04       Impact factor: 5.203

5.  Clinical, epidemiological and therapeutic profile of patients with brachioradial pruritus in a reference service in dermatology.

Authors:  Ana Cecília Versiani Duarte Pinto; Patrick Alexander Wachholz; Paula Yoshiko Masuda; Antonio Carlos Ceribelli Martelli
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

6.  Advanced aging skin and itch: addressing an unmet need.

Authors:  Lilit Garibyan; Albert S Chiou; Sarina B Elmariah
Journal:  Dermatol Ther       Date:  2013 Mar-Apr       Impact factor: 2.851

7.  Sensory TRP channels contribute differentially to skin inflammation and persistent itch.

Authors:  Jing Feng; Pu Yang; Madison R Mack; Dariia Dryn; Jialie Luo; Xuan Gong; Shenbin Liu; Landon K Oetjen; Alexander V Zholos; Zhinan Mei; Shijin Yin; Brian S Kim; Hongzhen Hu
Journal:  Nat Commun       Date:  2017-10-30       Impact factor: 14.919

8.  Maternal serum but not breast milk IL-5, IL-6, and IL-13 immune markers are associated with scratching among infants.

Authors:  Nelís Soto-Ramírez; Keith Boyd; Hongmei Zhang; Venugopal Gangur; Laura Goetzl; Wilfried Karmaus
Journal:  Allergy Asthma Clin Immunol       Date:  2016-05-24       Impact factor: 3.406

9.  Investigating endogenous µ-opioid receptors in human keratinocytes as pharmacological targets using novel fluorescent ligand.

Authors:  Cheryl Leong; Christine Neumann; Srinivas Ramasamy; Bhimsen Rout; Lim Yi Wee; Mei Bigliardi-Qi; Paul L Bigliardi
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

10.  Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System.

Authors:  Graça M Dores; Silvia Perez-Vilar; Manette T Niu
Journal:  J Pharm Health Care Sci       Date:  2019-12-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.